Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
Dicks Mdj., Matthew G. Cottingham(University of Oxford), Alexandra J. Spencer(University of Oxford), Sue Hill, Sophie Gilbert(Arthritis UK), Nigel Edwards(Confederation College)
Human Gene Therapy
January 1, 2011
Cited by 0
Related Papers
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
|PLoS ONE|2012|398
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
|Scientific Reports|2017|266
Viral vectors as vaccine platforms: deployment in sight
|Current Opinion in Immunology|2011|207
Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass
|Science Translational Medicine|2010|166